Cardiac Ablation Market By Procedure Type ( SVT Ablation, Atrial Flutter Ablation, Pulmonary Vein Isolation, Ventricular Tachycardia Ablation ), By Technology ( Cryoablation, Electrical Ablation, Microwave Ablation, Ultrasound Ablation, Radiofrequency (RF) Ablation ), By Application ( Cardiac Rhythm Management, Open Surgery ), Industry Trends, Estimation & Forecast, 2017-2025

Check Today's Best Price

$3500 Buy Now
Cardiac Ablation Market is expected to grow with a CAGR of 7.8% during the forecast period of 2018 to 2025.
  • Market Overview:

    Cardiac ablation is a cardiovascular medical procedure that regulates the abnormal heart rhythms by destroying the damaged tissues of the heart. Advancements in technology have led to the advent of various technologies through which scarring of damaged heart tissues can be carried out. Radiofrequency (RF) ablation and cryoablation are the two most widely used technologies for conducting cardiac ablation. The global cardiac ablation market is expected to witness an impressive growth rate during the upcoming years due to the surge in number of cardiovascular diseases and the sedentary lifestyle of people.

    According to the American College of Cardiology, nearly 800,000 deaths in the United States occur due to cardiovascular diseases. On a global platform, approximately 31% of the deaths that occur across the globe are due to cardiovascular diseases. Such high statistics are expected to boost the demand for cardiac ablation in the global market. In terms of region, North America is anticipated to garner a significant share of the global market, owing to the changing lifestyle of people and higher incidences of cardiovascular diseases in the region.

    The report provides detailed qualitative and quantitative analysis of the cardiac ablation market. Market size and forecast in terms of value and volume has been provided for the period – (2017 – 2025), for the segments namely procedure type, technology, and application in each of the major regions.

    Cardiac Ablation Market Segmentation

    By Procedure type

    • SVT ablation
    • Atrial flutter ablation
    • Pulmonary vein isolation
    • Ventricular tachycardia ablation

    By Technology

    • Cryoablation
    • Electrical Ablation
    • Microwave Ablation
    • Ultrasound Ablation
    • Radiofrequency (RF) Ablation

    By Application

    • Cardiac Rhythm Management
    • Open Surgery
    • Others

    By Geography

    • North America

    o U.S.
    o Canada
    o Mexico

    • Europe

    o U.K.
    o France
    o Germany
    o Italy
    o Spain
    o Rest of Europe

    • Asia-Pacific

    o China
    o Japan
    o India
    o Korea
    o Rest of APAC

    • South America

    o Brazil
    o Rest of South America

    • Rest of the World

    o Middle East
    o Africa

    keyboard_arrow_up
  • CHAPTER 1. INTRODUCTION
    1.1. RESEARCH METHODOLOGY
    1.1.1. ERC desk research
    1.1.2. ERC data synthesis
    1.1.3. Data validation and market feedback
    1.1.4. ERC data sources

    CHAPTER 2. CARDIAC ABLATION MARKET OVERVIEW
    2.1. CARDIAC ABLATION MARKET INTRODUCTION
    2.2. GLOBAL CARDIAC ABLATION MARKET REVENUE AND GROWTH RATE, 2017-2025
    2.2.1. Global Cardiac Ablation Market Revenue (Million USD) and Growth Rate (%), (2017-2025)

    CHAPTER 3. GLOBAL CARDIAC ABLATION MARKET BY PROCEDURE TYPE, 2017-2025
    3.1. SVT ABLATION
    3.2. ATRIAL FLUTTER ABLATION
    3.3. PULMONARY VEIN ISOLATION
    3.4. GLOBAL CARDIAC ABLATION MARKET REVENUE BY PROCEDURE TYPE, 2017-2025
    3.4.1. Global Cardiac Ablation Market Revenue (Million USD) and Share (%) By Procedure type, 2017-2025
    3.4.2. SVT ablation Market Revenue and Growth Rate, 2017-2025
    3.4.3. Atrial flutter ablation Market Revenue and Growth Rate, 2017-2025
    3.4.4. Pulmonary vein isolation Market Revenue and Growth Rate, 2017-2025

    Note: Similar information coverage has been provided for other procedure type segment.

    CHAPTER 4. GLOBAL CARDIAC ABLATION MARKET BY APPLICATION, 2017-2025
    4.1. CARDIAC RHYTHM MANAGEMENT
    4.2. OPEN SURGERY
    4.3. OTHERS
    4.4. GLOBAL CARDIAC ABLATION MARKET REVENUE BY APPLICATION, 2017-2025
    4.4.1. Global Cardiac Ablation Market Revenue (Million USD) and Share (%) By Application, 2017-2025
    4.4.2. Cardiac Rhythm Management Market Revenue and Growth Rate, 2017-2025
    4.4.3. Open Surgery Market Revenue and Growth Rate, 2017-2025
    4.4.4. Others Market Revenue and Growth Rate, 2017-2025

    Note: Similar information coverage has been provided for other application and technology segment.

    CHAPTER 5. GLOBAL CARDIAC ABLATION MARKET BY REGION, 2017-2025
    5.1. NORTH AMERICA
    5.1.1. U.S.
    5.1.2. Canada
    5.1.3. Mexico
    5.2. EUROPE
    5.2.1. U.K.
    5.2.2. France
    5.2.3. Germany
    5.2.4. Italy
    5.2.5. Spain
    5.2.6. Rest of Europe
    5.3. ASIA PACIFIC
    5.3.1. China
    5.3.2. Japan
    5.3.3. India
    5.3.4. Korea
    5.3.5. Rest of APAC
    5.4. SOUTH AMERICA
    5.4.1. Brazil 23
    5.4.2. Rest of South America
    5.5. REST OF THE WORLD
    5.5.1. Middle East
    5.5.2. Africa
    5.6. GLOBAL CARDIAC ABLATION MARKET REVENUE BY REGION, 2017-2025
    5.6.1. Global Cardiac Ablation Market Revenue (Million USD) and Share (%) By Region, 2017-2025
    5.6.2. North America Market Revenue and Growth Rate, 2017-2025
    5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
    5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
    5.6.5. South America Market Revenue and Growth Rate, 2017-2025
    5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025

    CHAPTER 6. MARKET DETERMINANTS
    6.1. MARKET DRIVERS
    6.2. MARKET RESTRAINTS
    6.3. MARKET OPPORTUNITIES
    6.4. MARKET DETERMINANTS RADAR CHART

    CHAPTER 7. GLOBAL CARDIAC ABLATION MARKET COMPETITION BY SERVICE PROVIDERS
    7.1. GLOBAL CARDIAC ABLATION REVENUE AND SHARE BY SERVICE PROVIDERS (2017-2025)
    7.1.1. Global Cardiac Ablation Revenue (Million USD) and Share (%) by Service Providers (2017-2025)
    7.2. CARDIAC ABLATION MARKET COMPETITIVE SITUATION AND TRENDS
    7.2.1. Cardiac Ablation Market Share (%) of Top 3 Service Providers
    7.2.2. Cardiac Ablation Market Share (%) of Top 5 Service Providers

    CHAPTER 8. COMPANY PROFILES
    8.1. ALCON LABORATORIES INC.
    8.1.1. Business Overview
    8.1.2. Company Basic Information
    8.1.3. Cardiac Ablation Product Details
    8.1.4. Alcon Laboratories Inc. Cardiac Ablation Revenue and Gross Margin
    8.2. ADVANCED CARDIAC THERAPEUTICS
    8.2.1. Business Overview
    8.2.2. Company Basic Information
    8.2.3. Cardiac Ablation Product Details
    8.2.4. Advanced Cardiac Therapeutics Cardiac Ablation Revenue and Gross Margin
    8.3. BIOSCIENCE WEBSTER
    8.3.1. Business Overview
    8.3.2. Company Basic Information
    8.3.3. Cardiac Ablation Product Details
    8.3.4. Bioscience Webster Cardiac Ablation Revenue and Gross Margin
    8.4. ATRICURE INC.
    8.4.1. Business Overview
    8.4.2. Company Basic Information
    8.4.3. Cardiac Ablation Product Details
    8.4.4. Atricure Inc. Cardiac Ablation Revenue and Gross Margin
    8.5. ST. JUDE MEDICAL, INC.
    8.5.1. Business Overview
    8.5.2. Company Basic Information
    8.5.3. Cardiac Ablation Product Details
    8.5.4. St. Jude Medical, Inc. Cardiac Ablation Revenue and Gross Margin
    8.6. ABLACOR
    8.6.1. Business Overview
    8.6.2. Company Basic Information
    8.6.3. Cardiac Ablation Product Details
    8.6.4. Ablacor Cardiac Ablation Revenue and Gross Margin
    8.7. MOUNT SINAI CORPORATION
    8.7.1. Business Overview
    8.7.2. Company Basic Information
    8.7.3. Cardiac Ablation Product Details
    8.7.4. Mount Sinai Corporation Cardiac Ablation Revenue and Gross Margin
    8.8. BOSTON SCIENTIFIC CORPORATION
    8.8.1. Business Overview
    8.8.2. Company Basic Information
    8.8.3. Cardiac Ablation Product Details
    8.8.4. Boston Scientific Corporation Cardiac Ablation Revenue and Gross Margin
    8.9. CONMED CORPORATION
    8.9.1. Business Overview
    8.9.2. Company Basic Information
    8.9.3. Cardiac Ablation Product Details
    8.9.4. Conmed Corporation Cardiac Ablation Revenue and Gross Margin
    8.10. COVIDIEN
    8.10.1. Business Overview
    8.10.2. Company Basic Information
    8.10.3. Cardiac Ablation Product Details
    8.10.4. Covidien Cardiac Ablation Revenue and Gross Margin

    CHAPTER 9. CARDIAC ABLATION MARKET VALUE CHAIN ANALYSIS
    9.1. CARDIAC ABLATION INDUSTRIAL CHAIN ANALYSIS
    9.2. CONSUMER ANALYSIS
    9.2.1. Consumer 1
    9.2.2. Consumer 2
    9.2.3. Consumer 3
    9.2.4. Consumer 4

    keyboard_arrow_up
  • • Alcon Laboratories Inc.
    • Advanced Cardiac Therapeutics
    • Bioscience Webster
    • Atricure Inc.
    • St. Jude Medical, Inc.
    • Ablacor
    • Mount Sinai Corporation
    • Boston Scientific Corporation
    • Conmed Corporation
    • Covidien
    • Ethicon
    • Olympus Corporation
    • Huainan Aofu Surgical
    • Medsphere
    • Medtronics Plc
    • Angiodynamics

    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Information does this report contain?

• What was the market size of the Cardiac Ablation Market in 2017 and the expected market size by 2025, along with the growth rate?
• An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
• Which are the largest revenue generating products, services or regions, and their comparative growth rate?
• Which technology is on trend and how would it evolve during the forecast period (2017 – 2025)?
• Which are the leading companies in the Cardiac Ablation Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

CLIENTS